Nephropathy from BK virus (BKV) infection is an evolving challenge in kidney transplant
recipients. It is the consequence of modern potent immunosuppression aimed at reducing …

Background. Polyomavirus-associated nephropathy (PVAN) is an important cause of kidney
graft loss but there is no consensus on its management. This study aimed to systematically …

BK virus interstitial nephritis (BKVIN) is a serious complication after kidney grafting,
necessitating drastic reduction of immunosuppressive therapy in order to enable viral …

Polyomavirus-associated nephropathy (PVAN) is managed by reduced immunosuppression
with or without antiviral therapy. Data from 55 patients with biopsy-proven PVAN were …

Antiviral drugs with specific activity against polyomavirus replication have not been
developed in the past. This deficiency has become fully apparent with the emergence of …

Abstract In 2019, there were about 100,000 kidney transplants globally, with more than a
quarter of them performed in the United States. Unfortunately, some engrafted organs are …

BK virus reactivation as a result of therapeutic immunosuppression following renal
transplant can result in BK polyomavirus nephropathy and renal allograft loss. This is a …

Background In renal transplantation, BK virus infection can result in significant graft
nephropathy and loss. While reduction in immunosuppression (IS) is considered standard …

Although patients with end-stage renal disease can be maintained with dialysis therapy, the
superiority of patient survival with renal transplantation makes transplantation the preferred …

Over the last decade, polyomavirus‐associated nephropathy (PVAN) has occurred with
increasing frequency after renal transplantation, leading to significant renal dysfunction and …